PICO Portalanswers from OpenAlex & ORCID
Daniel H. Palmer
ResearcherPublications, citations & collaboration network
Daniel H. Palmer is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Daniel H. Palmer have?
PICO Portalindexed works
Daniel H. Palmer has 407 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daniel H. Palmer have?
PICO Portalcitation count
Daniel H. Palmer has 32,616 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Daniel H. Palmer?
PICO Portalh-index
Daniel H. Palmer has an h-index of 63 in OpenAlex.
What is the i10-index of Daniel H. Palmer?
PICO Portali10-index
Daniel H. Palmer has an i10-index of 163 in OpenAlex.
What is the ORCID of Daniel H. Palmer?
PICO Portalorcid
The ORCID for Daniel H. Palmer is on the source record.
What is the OpenAlex record for Daniel H. Palmer?
PICO Portalopenalex
The OpenAlex for Daniel H. Palmer is on the source record.
What are the most-cited papers on Daniel H. Palmer?
PICO Portalmost cited works
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu, Richard S. Finn, Julien Edeline, Stéphane Cattan, Sadahisa Ogasawara, Daniel H. Palmer, Chris Verslype, Vittorina Zagonel, Lætitia Fartoux, Arndt Vogel, Debashis Sarker, Gontran Verset, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Andrea L. Webber, Scot Ebbinghaus, Junshui Ma, Abby B. Siegel, Ann‐Lii Cheng, Masatoshi Kudo, Angela Alistar, Jamil Asselah, Jean‐Frédéric Blanc, Ivan Borbath, Timothy Lewis Cannon, Ki Y. Chung, Allen Lee Cohn, David Cosgrove, Nevena Damjanov, Mukul Gupta, Yoshivasu Karino, Mark Karwal, Andreas Kaubisch, Robin Kate Kelley, Jena-Luc Van Laethem, Timothy Larson, James Lee, Daneng Li, Atisha Manhas, Gulam A. Manji, Kazushi Numata, Benjamin M. Parsons, Andrew Scott Paulson, Carmine Pinto, Robert A. Ramirez, Suresh Ratnam, Magnus Rizell, Olivier Rosmorduc, Yvonne H. Sada, Yutaka Sasaki, Per Stål, Simone I. Strasser, Joerg Trojan, Gina M. Vaccaro, Hans Van Vlierberghe, Alan Weiss, Karl-Heinz Weiss, Tatsuya Yamashita
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
Ángela Lamarca, Daniel H. Palmer, Harpreet Wasan, Paul J. Ross, Yuk Ting, Arvind Arora, Stephen Falk, Roopinder Gillmore, Jonathan Wadsley, Kinnari Patel, Alan Anthoney, Anthony Maraveyas, Timothy Iveson, Justin S. Waters, Claire Hobbs, Safia Barber, W. David J. Ryder, John Ramage, Linda Davies, John Bridgewater, Juan W. Valle